نتایج جستجو برای: myelodysplastic syndromes

تعداد نتایج: 86513  

Journal: :Nihon Naika Gakkai Zasshi 2015

Journal: :Clinical & Laboratory Haematology 2008

Journal: :Journal of Applied Hematology 2014

Journal: :Haematologica 2012
Jeffrey J Pu Rong Hu Galina L Mukhina Hetty E Carraway Michael A McDevitt Robert A Brodsky

BACKGROUND Patients with paroxysmal nocturnal hemoglobinuria harbor clonal glycosylphosphatidylinositol-anchor deficient cells arising from a multipotent hematopoietic stem cell acquiring a PIG-A mutation. Many patients with aplastic anemia and myelodysplastic syndromes also harbor small populations of glycosylphosphatidylinositol-anchor deficient cells. Patients with aplastic anemia often evol...

Journal: :The Western journal of medicine 1989
D C Doll A F List

The myelodysplastic syndromes are a heterogeneous group of hematopoietic stem cell disorders characterized by dysplastic and ineffective hematopoiesis and a varying risk of transformation to acute leukemia. Although the natural history of these syndromes is variable, several factors appear to be of prognostic importance, including the French-American-British classification, the karyotype, in vi...

Journal: :Clinics in laboratory medicine 1996
H P Koeffler

These two issues of the Seminars in Hematology will provide the physician the necessary knowledge to help make sense of this somewhat confusing array of diseases. The subdivisions of MDS reflect the precision of our techniques of dissection, with morphological and histochemical analyses forming the foundation to identify and subdivide MDS. Although steady refinement has occurred over the last h...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2002
Peter L Greenberg Eyal Attar Minoo Battiwalla John M Bennett Clara D Bloomfield Carlos M DeCastro H Joachim Deeg Harry P Erba James M Foran Guillermo Garcia-Manero Steven D Gore David Head Lori J Maness Michael Millenson Stephen D Nimer Margaret R O'Donnell Hussain I Saba Paul J Shami Kathy Spiers Richard M Stone Martin S Tallman Peter Westervelt

There has been a remarkable explosion of knowledge into the molecular defects that underlie the acute and chronic leukemias, leading to the introduction of targeted therapies that can block key cellular events essential for the viability of the leukemic cell. Our understanding of the pathogenesis of the myelodysplastic syndromes (MDSs) has lagged behind, at least in part, because they represent...

Journal: :Hematology. American Society of Hematology. Education Program 2004
Eric Solary Michaëla Fontenay

Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic diseases with inefficient hematopoiesis. Diagnosis is based on the persistence of at least one cytopenia for more than 6 months, together with cytological and cytogenetic bone marrow abnormalities, a variety of other diagnosis being discarded. Most patients will die from the consequences of cytopenias. These disea...

2014
Paula de Melo Campos Fabiola Traina Irene Lorand-Metze Sara Teresinha Olalla Saad

Although myelodysplastic syndromes have a clear definition in theory, the morphologic dysplasia associated with ineffective hematopoiesis may be subtle and difficult to recognize and can commonly be mimicked by systemic conditions, such as infections, autoimmune disorders, nutritional deficiencies, toxic factors and non-hematological malignancies. However, myelodysplastic syndromes may truly co...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید